FairJourney Biologics
Miguel Marques is a highly experienced researcher specializing in antibody purification and production. Currently serving as a Senior Research Associate II at FairJourney Biologics since April 2019, Miguel focuses on the purification of monoclonal antibodies, bispecifics, multispecifics, and antibody fragments utilizing the AKTA system, along with various chromatography techniques. Prior roles include Research Associate at FairJourney Biologics and Research Fellow at i3S - Instituto de Investigação e Inovação em Saúde. Miguel holds a PhD in Biomedicine from the Universidade do Porto, a Master of Science in Applied Microbiology from the Universidade de Lisboa, and a Bachelor of Science in Microbiology from the same institution. Research efforts have notably centered on Helicobacter pylori and its impact on cell-cell junctions, under the guidance of esteemed professors throughout academic endeavors.
FairJourney Biologics
FairJourney Biologics is a privately established company with an outstanding track record of biotech and biopharmaceutical partners (Merus, argenX, BMS, Bayer, among others), offering a range of assets and services on antibody discovery, engineering, production, characterization up to cell line development stages. Our naïve and immune libraries from humans, rodents and llama, together with our know-how and internal technological development allow us to contribute to the pipeline of our partners on complex targets, leading to 14 known antibodies in the clinic. More recently, FairJourney Biologics has been joined by specialists in the field such as Tariq Ghayur (formerly Abbvie) and Rene Hoet (formerly Bayer), creating a panel of available scientists as service to support complex antibody projects. From target validation up to cell line development and pre-CMC reporting, FairJourney Biologics is a one stop shop leader in antibody services. As of 2022, the company has a headcount of above 200 staff members and a track record of more than 800 projects on a variety of areas.